Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen-assisted Treatment for Acute Severe Ulcerative Colitis
NCT07257588Enrolling by invitation
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Sep 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised trial in ulcerative colitis (UC) (2 arms), sponsored by Xijing Hospital of Digestive Diseases. Primary endpoint: Clinical response at 7 days. Started Sep 2024; status: enrolling by invitation.
02
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07257588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257588.